¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ »ç±¸Ã¼½Å¿° ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÅÀåÇÐȸ »ç±¸Ã¼½Å¿° ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-11-11
±³À°ÀÏÀÚ : 2018-11-11
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ 1Ãþ À±ÀιèȦ  
±³À°ÁÖÁ¦ : »ç±¸Ã¼½Å¿° ¿¬±¸È¸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : »ç±¸Ã¼½Å¿° ¿¬±¸È¸  
´ã´çÀÚ : ¾öÈ¿Á¤
¿¬¶ôó : 02-2228-2281  
À̸ÞÀÏ : hjum@yuhs.ac      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í »çÀüµî·Ï-2¸¸/ ÇöÀåµî·Ï-3¸¸      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 À±ÀιèȦ 08:30~09:00 Histopathologic predictors of renal outcome in lupus nephritis  Àå±â¼®(ÇѾç´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 09:00~09:30 Disease activity assessment of systemic lupus erythematosus: Application to clinical trial and real world practice  ÀÌÀº¿µ(¼­¿ï´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 09:30~10:00 Recent advances in the management of lupus nephritis  ¹Ú¼±Èñ(°æºÏ´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 10:15~10:45 Pathology and pathogenesis of C3 glomerulopathy and atypical HUS  ÇÑ°­¹Î(µ¿±¹´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 10:45~11:15 C3 glomerulopathy: Diagnosis and management  ÀÌÁ¤Àº(¼º±Õ°ü´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 11:15~11:45 Atypical HUS: Diagnosis and management  °­Èñ°æ(¼­¿ï´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 12:00~12:15 Glomerulonephritis in the elderly  ¾È½Å¿µ(°í·Á´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 12:15~12:30 Blood pressure and CKD progression in patients with glomerular diseases  ÇѽÂÇõ(¿¬¼¼´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 12:30~12:45 Renal outcome of biopsy-proven acute tubular necrosis and acute tubulointerstitial nephritis  ¿À¼¼¿ø(°í·Á´ë) 
±³À°½Ã°£ 11-11 À±ÀιèȦ 12:45~13:00 Clinical manifestation and prognosis of C1q nephropathy  ÁøÈ£ÁØ(¼­¿ï´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ »ç±¸Ã¼½Å¿° ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °­³²¼¼ºê¶õ½ºº´¿ø 2018µÎ°æºÎ°øµ¿½ÉÆ÷Áö¾ö(´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ& ´ëÇÑ°©»ó¼±µÎ°æºÎ¿Ü°úÇÐȸ °øµ¿ÁÖ°ü) : 2018-11-11
´ÙÀ½±Û ¼­¿ï´ëÇб³¾î¸°À̺´¿ø 2018³âµµ ´ëÇѼҾÆû¼Ò³âÁ¤Çü¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-11-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20499 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2024-05-11 0 54 2024-04-29
20498 ºÎ»ê ¸¸¼ºÆó¼â °ü»óµ¿¸Æ ÁßÀç½Ã¼ú¿¬±¸È¸ The 23rd K-CTO(Korean Chronic Total Occlusion Club) Live Demonstration : 2024-05-11 0 40 2024-04-29
20497 ¼­¿ï ´ëÇÑÀü¸³¼±ÇÐȸ The 3rd Korean Prostate Society Prostate Cancer Working Group Symposium : 2024-05-11 0 41 2024-04-29
20496 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11 0 24 2024-04-29
20495 ¼­¿ï Á¦77Â÷ ´ëÇÑû°¢ÇÐȸ Çмú´ëȸ : 2024-05-11 0 49 2024-04-29
20494 ÀÎõ Á¦9ȸ °¡Ãµ´ë ±æº´¿ø ½Å°æ¿Ü°ú ¾÷µ¥ÀÌÆ® ½ÉÆ÷Áö¿ò (G-NeUS) : 2024-05-11 0 50 2024-04-29
20493 ´ëÀü 2024³â ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Ãá°èÇмú´ëȸ & Basic Training Course : 2024-05-11 0 32 2024-04-29
20492 ±¤ÁÖ 2024³â ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Á¦37Â÷ Çмú´ëȸDAY2 : 2024-05-11 0 40 2024-04-29
20491 ¼­¿ï Á¦50ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-05-11 0 39 2024-04-29
20490 ¼­¿ï ÇѾç´ëÇб³º´¿ø Á¤Çü¿Ü°ú ⸳ 52Áֳ⠱â³äÇмú´ëȸ : 2024-05-11 0 81 2024-04-29
20489 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¼ºÇü¿Ü°úÇб³½Ç â¸³ 50Áֳ⠱â³ä Çмú´ëȸ : 2024-05-11 0 43 2024-04-29
20488 °æ±â ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (2ÀÏÂ÷) : 2024-05-11 0 47 2024-04-29
20487 °­¿ø 2024³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷) : 2024-05-10 0 43 2024-04-29
20486 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-10 0 69 2024-04-29
20485 ¼­¿ï ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ 2024 Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-05-10 0 37 2024-04-29
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷